News Conference News ESC Heart Failure 2021 Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR Shelley Wood July 06, 2021
News Daily News New HF Uncommon After COVID-19, but Rare Cases Pose Quandary Shelley Wood April 28, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Conference News PCR London Valves 2020 CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures Shelley Wood November 24, 2020
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Conference News AHA 2020 Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF Todd Neale November 16, 2020
News Daily News Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients L.A. McKeown December 06, 2019
News Conference News SCAI 2019 New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams Yael L. Maxwell May 22, 2019
News Industry News Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure February 25, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Conference News The Structural Heart Disease Summit 2018 Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms Michael O'Riordan June 27, 2018
News Daily News Respiratory Syncytial Virus Linked With Cardiovascular Complications Michael O'Riordan April 04, 2018
News Conference News ACC 2018 Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint Caitlin E. Cox March 19, 2018
News Conference News ACC 2018 Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018
Presentation TCT 2017 State-of-the-Art: Acute and Chronic Cardiopulmonary Support Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama November 01, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines Todd Neale February 03, 2017
News Conference News ESC 2016 N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before Shelley Wood August 28, 2016